Ischaemic heart-disease in diabetes

Collecting data on potentially harmful events: a method for monitoring incidents in general practice.

Family practice·1997

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers.

Clinical pharmacology and therapeutics·1992

Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.

The Journal of rheumatology. Supplement·1991

Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam.

The Journal of rheumatology. Supplement·1990

Recent advances in defining the role of misoprostol in rheumatology.

The Journal of rheumatology. Supplement·1990

A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

Digestive diseases and sciences·1986

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Revista colombiana de obstetricia y ginecologia·2026

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

The Medical journal of Malaysia·2026

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Journal of the American College of Cardiology·2026

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Journal of the American College of Cardiology·2026

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Journal of viral hepatitis·2026

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Related Experiment Videos

Ischaemic heart-disease in diabetes

Related Concept Videos

Collecting data on potentially harmful events: a method for monitoring incidents in general practice.

Effects of misoprostol on the pharmacokinetics of indomethacin in human volunteers.

Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.

Pharmacokinetics of misoprostol in the elderly, in patients with renal failure and when coadministered with NSAID or antipyrine, propranolol or diazepam.

Recent advances in defining the role of misoprostol in rheumatology.

A multicenter international controlled comparison of two dosage regimens of misoprostol with cimetidine in treatment of gastric ulcer in outpatients.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

Related Experiment Videos

Ischaemic heart-disease in diabetes

Related Concept Videos

Related Articles